Biopharmaceutical Firm, ViroPharma, Expands In Exton, Pa, Creating 151 New Jobs
09/14/2012
ViroPharma said it will nearly double its current available space by leasing an additional 71,000-square feet of office space at 730 Stockton Drive to accommodate planned growth. The expansion will enable the company hire at least 151 employees to its workforce of 188 within three years.
"For us it is about growth. ViroPharma has been in Exton for many years and we love our home here," said ViroPharma President and CEO Vincent J. Milano. "We're committed to this area for the long-term and look forward to creating opportunities in this community."
"ViroPharma is a true Pennsylvania success that continues to grow and create jobs in the region," said Gov. Tom Corbett. "What started as a small team of entrepreneurs in Exton has now evolved into an international biopharmaceutical company employing hundreds of Pennsylvanians.
As an incentive, the company received $583,000 in funding from the Department of Community and Economic Development, including a $130,000 Pennsylvania First grant and $453,000 in Job Creation Tax Credits.
"Chester County is fortunate to have companies like ViroPharma who continually innovate and reinvent themselves," said Chester County Economic Development Council President and CEO Gary Smith. "Their expansion is the latest evidence that the life science community in Chester County is alive and well." The amount of the company's capital investment was not immediately available.
Project Announcements
Grupo Vialume Plans Colquitt, Georgia, Production Operations
12/19/2025
RelaDyne Expands Hebron, Kentucky, Operations
12/19/2025
Kroger Plans Simpson County, Kentucky, Distribution Operations
12/19/2025
Hines Furlong Line Expands Paducah, Kentucky, Operations
12/19/2025
Swisher Expands Jacksonville, Florida, Manufacturing Operations
12/19/2025
Epic Piping Upgrades Livingston, Louisiana, Operations
12/19/2025
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Rethinking Local Governments Through Consolidation and Choice
Q3 2025
-
Lead with Facts, Land the Deal
Q3 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
America’s Aerospace Reboot
Q3 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
The Permit Puzzle and the Path to Groundbreaking
Q3 2025